News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hemosphere Exceeds 4000 HeRO Grafts Sold – Rapid Therapy Adoption at Leading Best Practice Centers Aligns with Blood-Stream Infection (BSI) Reduction Initiatives



8/16/2011 10:20:46 AM

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Hemosphere, Inc., developer of the HeRO® Graft for hemodialysis access, announced that another sales record was achieved. Last week, Hemosphere sold the 4000th HeRO® Graft marking a new milestone in the company’s history.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES